Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 10/20 | 0.77 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.77 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.71 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.71 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.71 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.71 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.71 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.71 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.71 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.71 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.71 |
| ▸ | FDPS | P14324 | 2/20 | 0.65 |
| ▸ | MAOB | P27338 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 4/20 | 0.55 |
| ▸ | BCHE | P06276 | 3/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18265477 | 0.87 | MTNR1A (1.00) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL16792056 | 0.87 | MTNR1A (1.00) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL18265494 | 0.86 | MTNR1A (0.98) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL16792042 | 0.86 | MTNR1A (0.98) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL30302461 | 0.84 | PTGES (0.73) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL29145012 | 0.84 | PTGES (0.73) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL18585756 | 0.84 | PTGES (0.73) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL16692678 | 0.84 | PTGES (0.77) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL18010087 | 0.84 | PTGES (0.77) | PTGESMTNR1AHDAC3HDAC4HDAC1 | |
| SCHEMBL7030591 | 0.83 | PTGES (0.52) | PTGESMTNR1AHDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160375041-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS | TABACZYNSKI DAVID A (US) | 2016-12-29 | — | — | US | disclosed |
| US-20160303146-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | TABACZYNSKI DAVID A (US) | 2016-10-20 | — | — | US | disclosed |
| WO-2015089349-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | TABACZYNSKI DAVID A (US) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015084721-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS | TABACZYNSKI DAVID A (US) | 2015-06-11 | — | — | WO | disclosed |
| US-20030064119-A1 | Methods and compositions for applying essential oils and naturally occurring compounds to plants to activate endogenous plant pathogen defense pathways | EMERSON RALPH W (US) | 2003-04-03 | — | — | US | disclosed |
| WO-2003000288-A1 | METHODS AND COMPOSITIONS FOR ACTIVATING ENDOGENOUS PLANT PATHOGEN DEFENSE PATHWAYS | THE BANKS GROUP, LLC (US) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160375041-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS | GGPS1, FDPS, COASY | PTGES 406/4885MTNR1A 3430/4885HDAC3 4034/4885 |
| US-20160303146-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | GGPS1, FDPS, COASY | PTGES 30/4885MTNR1A 2496/4885HDAC3 3786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.